Unlike many known expression-survival associations in melanoma, transcriptomic pathway analysis did not support an immune pathway-mediated effect (Fig. 2i, Tables S3, S4), leading us to look for an alternative mechanism of action of PPP2R3B overexpression on melanocytic proliferation. The gene discussed is PPP2R3B; the disease is melanoma.